Basil Michelle L has filed 20 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 6755 shares of HAEMONETICS CORP ($HAE) on May 16, 2025.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | A | Common Stock | 6755 | $0.00 | 35,233.0000 | 50,730,000 | 23.72% | 0.01% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | A | Non-qualified Stock Option (Right to Buy) | 14626 | $0.00 | 14,626.0000 | 50,730,000 | 9999.99% | 0.03% |
| May 30, 2025 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | F | Common Stock | 7469 | $69.38 | 42,252.0000 | 50,730,000 | 15.02% | 0.01% |
| May 30, 2025 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | A | Common Stock | 15554 | $0.00 | 49,721.0000 | 50,730,000 | 45.52% | 0.03% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | A | Non-qualified Stock Option (Right to Buy) | 12317 | $0.00 | 12,317.0000 | 50,730,000 | 9999.99% | 0.02% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | A | Common Stock | 5689 | $0.00 | 34,167.0000 | 50,730,000 | 19.98% | 0.01% |
| May 15, 2025 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | F | Common Stock | 622 | $69.38 | 30,635.0000 | 50,730,000 | 1.99% | 0.00% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | F | Common Stock | 2157 | $70.31 | 28,478.0000 | 50,730,000 | 7.04% | 0.00% |
| May 29, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | S | Common Stock | 8896 | $87.86 | 35,351.0000 | 51,397,000 | 20.11% | 0.02% |
| May 29, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | S | Common Stock | 4094 | $88.57 | 31,257.0000 | 51,397,000 | 11.58% | 0.01% |
| May 28, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | A | Common Stock | 24748 | $0.00 | 56,005.0000 | 51,397,000 | 79.18% | 0.05% |
| May 28, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | F | Common Stock | 11758 | $95.73 | 44,247.0000 | 51,397,000 | 20.99% | 0.02% |
| May 20, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | S | Common Stock | 1604 | $95.08 | 31,257.0000 | 51,397,000 | 4.88% | 0.00% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | F | Common Stock | 669 | $95.73 | 28,683.0000 | 51,397,000 | 2.28% | 0.00% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | A | Common Stock | 4178 | $0.00 | 32,861.0000 | 51,397,000 | 14.57% | 0.01% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | A | Non-qualified Stock Option (Right to Buy) | 9183 | $0.00 | 9,183.0000 | 51,397,000 | 9999.99% | 0.02% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | S | Common Stock | 1073 | $95.00 | 29,352.0000 | 51,397,000 | 3.53% | 0.00% |
| May 15, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | F | Common Stock | 416 | $96.49 | 31,856.0000 | 51,397,000 | 1.29% | 0.00% |
| May 16, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | F | Common Stock | 446 | $94.80 | 31,410.0000 | 51,397,000 | 1.40% | 0.00% |
| May 16, 2024 | HAEMONETICS CORP | $HAE | Basil Michelle L | EVP and General Counsel | S | Common Stock | 985 | $96.14 | 30,425.0000 | 51,397,000 | 3.14% | 0.00% |